InspireMD Inc.

Contributing Author

Recent Articles by InspireMD Inc.

Jan-20	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NSPR GlobeNewswire
Jan-12	InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC) NSPR GlobeNewswire
Nov-24	Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting NSPR GlobeNewswire
Nov-21	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NSPR GlobeNewswire
Nov-19	InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference NSPR GlobeNewswire
Nov-04	InspireMD Reports Third Quarter 2025 Financial Results NSPR GlobeNewswire
Nov-03	InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer NSPR GlobeNewswire
Oct-21	InspireMD to Announce Third Quarter 2025 Financial Results NSPR GlobeNewswire
Oct-08	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NSPR GlobeNewswire
Sep-25	InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) NSPR GlobeNewswire
Sep-17	InspireMD Announces the Appointment of Dan Dearen to its Board of Directors NSPR GlobeNewswire
Aug-27	InspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment Conference NSPR GlobeNewswire
Aug-05	InspireMD Reports Second Quarter 2025 Financial Results NSPR GlobeNewswire
Jul-31	InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors NSPR GlobeNewswire
Jul-31	InspireMD Announces Combined Financings of $58 Million NSPR GlobeNewswire
Jul-22	InspireMD to Announce Second Quarter 2025 Financial Results NSPR GlobeNewswire
Jul-09	InspireMD Announces U.S. Commercial Launch of CGuard Prime Carotid Stent System for the Prevention of Stroke NSPR GlobeNewswire
Jun-24	InspireMD Announces FDA Approval for CGuard Prime Carotid Stent System for the Prevention of Stroke NSPR GlobeNewswire
Jun-13	InspireMD Announces CE Mark Approval for CGuard Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke NSPR GlobeNewswire
Jun-03	InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer NSPR GlobeNewswire
May-09	InspireMD Reports First Quarter 2025 Financial Results NSPR GlobeNewswire
Apr-30	InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference NSPR GlobeNewswire
Apr-30	InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference NSPR GlobeNewswire

InspireMD Inc.

Recent Articles by InspireMD Inc.

Upgrade your FINVIZ experience